Pharma market

GlobalData’s Ulcerative Colitis Market Forecast expects Zeposia to have sales of $374.2 million worldwide in 2031, compared to…

Shelja Jose Kuruvilla, Head – Knowledge and Research, Vector Consulting Group underscores that the Indian pharma industry faces…

Dr Reddy’s Laboratories, Emcure Pharma, Hetero Drugs and Mylan Labs (a subsidiary of Viatris), are among the six companies that…

Revenues estimated to increase by 9-11 per cent from the US market, and 7-9 per cent each from the European and the domestic…

The resultant improvement in operating leverage along with easing pricing pressure in the US generics market will improve…

Mirabegron Extended-Release Tablets, 50 mg had estimated annual sales of $ 1,600 million in the US (IQVIA MAT July 2024)

The approval could present a major challenge to Ocaliva (obeticholic acid), which was until recently the sole approved drug for…

Under the terms of the agreement, Organon will become the sole distributor and promoter of Emgality in the following additional…

The lifesciences sector also reported 73 VC deals worth $2.5 billion

The pharma industry reported 88 VC deals worth $2.5B in June 2024, compared to the last 12-month (June 2023 to May 2024) average…